 |
 |
Thanks for forwarding the post. It was very interesting. Has anyone had personal experience with any of this research, especially regarding the new dopamine agonists (Cabergoline, Ropinerole or Pramipexole) or the COMT blocker Tolcapone? Or does anyone have further information or references regarding these studies? If so, please post to the group. Thanks, Joanna